Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K P Patel

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
British Journal of Cancer|October 15, 2014
Clinical massively parallel next-generation sequencing analysis of 409 cancer-related genes for mutations and copy number variations in solid tumoursR R Singh, K P Patel, M J Routbort, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2020
Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutationsV Subbiah, T Shen, S S Terzyan, et al.
Neuroscience|December 3, 2014
Cardiovascular and behavioral effects produced by administration of liposome-entrapped GABA into the rat central nervous systemG C Vaz, A P C O Bahia, F C de Figueiredo Müller-Ribeiro, et al.
ESMO Open|June 3, 2025
Clinical outcomes of tumor-agnostic targeting of BRAF, tumor mutation burden-high, and RETA Ronaghy, E Crimini, V R Holla, et al.
Blood|January 15, 2020
Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AMLC D DiNardo, I S Tiong, A Quaglieri, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
British Journal of Cancer|October 15, 2014
Clinical massively parallel next-generation sequencing analysis of 409 cancer-related genes for mutations and copy number variations in solid tumoursR R Singh, K P Patel, M J Routbort, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2020
Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutationsV Subbiah, T Shen, S S Terzyan, et al.
Neuroscience|December 3, 2014
Cardiovascular and behavioral effects produced by administration of liposome-entrapped GABA into the rat central nervous systemG C Vaz, A P C O Bahia, F C de Figueiredo Müller-Ribeiro, et al.
ESMO Open|June 3, 2025
Clinical outcomes of tumor-agnostic targeting of BRAF, tumor mutation burden-high, and RETA Ronaghy, E Crimini, V R Holla, et al.
Blood|January 15, 2020
Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AMLC D DiNardo, I S Tiong, A Quaglieri, et al.
Pageof 12